Meeting
2023 ASCO Annual Meeting
Detection of early-stage cancers using circulating orphan non-coding RNAs in blood.
Authors
Mehran Karimzadeh
Exai Bio Inc., Palo Alto, CA
Mehran Karimzadeh , Jeffrey Wang , Taylor B. Cavazos , Lee S. Schwartzberg , Michael Multhaup , Jeremy Ku , Xuan Zhao , Jieyang Wang , Kathleen Wang , Rose Hanna , Patrick Arensdorf , Kimberly H Chau , Helen Li , Hani Goodarzi , Lisa Fish , Fereydoun Hormozdiari , Babak Alipanahi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3051)
DOI
10.1200/JCO.2023.41.16_suppl.3051
Abstract #
3051
Poster Bd #
249
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Correlation of unobserved incidence of cancer in earlier stages with the observed incidence.
First Author: Jagpreet Chhatwal
Poster
2023 ASCO Genitourinary Cancers Symposium
Radical nephroureterectomy followed by adjuvant chemotherapy (RNU-AC) versus observation (RNU-O) in early-stage upper urinary tract cancers with variant histology (UUTC-VH).
First Author: Karan Jatwani
Poster
2022 ASCO Genitourinary Cancers Symposium
Actionable genomic landscapes from a real-world cohort of localized urothelial carcinoma patients.
First Author: Thomas Gerald
Poster
2020 Genitourinary Cancers Symposium
Sensitive detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
First Author: Pier Vitale Nuzzo